COMMUNIQUÉS West-GlobeNewswire

Hinds Hospice Partners with Elemeno Health to Provide Superior Patient Care
26/02/2019
Hinds first Hospice Organization to Implement Cloud-based Solution Enabling Caregivers to Improve Quality of Service and Patient Experience OAKLAND, Calif. and FRESNO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Elemeno [...]
GW Pharmaceuticals to Present at Upcoming Investor Conferences
26/02/2019
- Leerink Partners 8 th Annual Global Healthcare Conference on February 28, 2019 - - Cowen and Company 39 th Annual Health Care Conference on March 11, 2019 - LONDON and CARLSBAD, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE [...]
Tauriga Sciences Inc. Completes Production of Initial Inventory Tranche of its CBD Infused Chewing Gum
26/02/2019
New York, NY, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Innovation Pharmaceuticals Forms Irish Subsidiary to Facilitate International Development of Clinical Pipeline
26/02/2019
BEVERLY, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Companies Registration Office [...]
Cutera Announces Global Commercial Launch Of the excel V+® the Next Generation Laser Platform
26/02/2019
Developed in Collaboration with Leading Dermatologists, For Indications in Vascular, Skin and Pigmentation Treatments WASHINGTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- On the eve of the 2019 American Academy of Dermatology [...]
Medtronic Resolute(TM) Drug-Eluting Stent (DES) Platform Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO)
26/02/2019
FDA Approval Allows Interventional Cardiologists Access to Resolute DES Technology to Treat De Novo CTO DUBLIN - February 26, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) [...]
Scapa Healthcare Announces Hydrocolloid Offering for Acne Treatment
26/02/2019
Acne Patches Provide a Protective and Absorbent Barrier to Reduce Size and Redness of Blemishes WINDSOR, Conn., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Scapa Healthcare , a global strategic outsource partner of skin friendly [...]
IlluminOss Medical Launches the IlluminOss® Bone Stabilization System for Use in the Treatment of Traumatic and Fragility Fractures in the U.S.
26/02/2019
The Company’s Innovative Fracture Repair Technology Provides a New and Compelling Solution for Fragility Fractures Associated with the Aging Population EAST PROVIDENCE, R.I., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IlluminOss [...]
Rhinogram Telehealth Capabilities Now Integrated Into Cloud 9 Software Practice Management Solution
26/02/2019
Integration allows for better patient engagement while streamlining practice workflow CHATTANOOGA, Tenn., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Rhinogram , a leader in cloud-based, HIPAA-compliant, telehealth solutions, [...]
LHC Group and Geisinger announce definitive agreement for home health and hospice joint venture
26/02/2019
LAFAYETTE, La. and DANVILLE, Pa., Feb. 26, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG), Geisinger Home Health and Hospice, and AtlantiCare Home Health and Hospice announced today they have entered into a [...]
Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis
26/02/2019
New resources offer important information about the diagnosis process, including the role of advanced lab tests San Diego, CA and Washington, DC, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Exagen, a life science company serving [...]
PotNetwork News Debuts First Issue of Its In-Depth Print Magazine, "PotNetwork”
26/02/2019
Inaugural print issue of the sector's number one news site features exclusive interviews and content with business leaders MIAMI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork News, www.potnetwork.com [...]
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
26/02/2019
REDWOOD CITY, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will present at two upcoming investor healthcare conferences. Management will [...]
Chinese-Based MedCDx and US-Based Admera Health Enter Into Strategic Partnership to Co-Develop Companion Diagnostics
26/02/2019
SOUTH PLAINFIELD, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen Suzhou Translational [...]
NRC Health Hosts 2019 Pediatric Collaborative at Dayton Children’s Hospital
26/02/2019
Industry Leaders Invited to Network, Discuss Unique Challenges Facing Pediatric Healthcare Organizations Today, and Brainstorm Solutions to Solve Them LINCOLN, Neb., Feb. 26, 2019 (GLOBE NEWSWIRE) -- NRC Health , the [...]
Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates
26/02/2019
RALEIGH, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics [...]
Marinus Announces Leadership Transition
26/02/2019
RADNOR, Penn., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
AXIM® Biotechnologies Announces Successful Microencapsulation of Cannabinoids Into Proprietary Chewing Gum Delivery Mechanism for Clinical Trials
26/02/2019
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the company has successfully [...]
VistaGen Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
26/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]

Pages